A detailed history of B&L Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, B&L Asset Management LLC holds 57,961 shares of NVO stock, worth $6.26 Million. This represents 4.36% of its overall portfolio holdings.

Number of Shares
57,961
Holding current value
$6.26 Million
% of portfolio
4.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $6.9 Million - $8.43 Million
57,961 New
57,961 $6.9 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track B&L Asset Management LLC Portfolio

Follow B&L Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B&L Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on B&L Asset Management LLC with notifications on news.